 |
Somatrem for injection |
|---|---|
| Trade Name | Protropin |
| Orphan Indication | For long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion |
| USA Market Approval | USA |
| USA Designation Date | 1985-12-09 00:00:00 |
| Sponsor | Genentech, Inc.;460 Point San Bruno Boulevard;South San Francisco, CA, 94080 |
